)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Interpace Biosciences (IDXG) investor relations material
Interpace Biosciences Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary12 Nov, 2025
Executive summary
Q3 2025 revenue was $8.8M, down 29% year-over-year, primarily due to the loss of Medicare coverage for PancraGEN® and subsequent discontinuation, but with record thyroid test volumes and cash collections of $10.0M.
Net income for Q3 2025 was $0.9M, compared to $1.7M in Q3 2024; for the nine months ended September 30, 2025, net income was $1.9M, down from $4.8M in the prior year period.
The company transitioned to a thyroid-only diagnostics business, focusing on ThyGeNEXT and ThyraMIRv2 platforms.
A restructuring plan was implemented in response to the loss of PancraGEN® coverage, resulting in workforce reductions and $0.7M in severance and related costs.
Strategic investments in laboratory efficiency, AI, and automation supported operational improvements and additional principal payments on long-term debt.
Financial highlights
Gross profit for Q3 2025 was $5.4M (62% margin), down from $7.9M (64% margin) in Q3 2024, but up from $7.3M pro forma (57% margin, excluding PancraGEN).
Operating income from continuing operations for Q3 2025 was $1.1M, compared to $2.3M in Q3 2024 and a $0.1M loss pro forma.
Adjusted EBITDA for Q3 2025 was $1.3M, down from $2.5M in Q3 2024, but up from $0.1M pro forma; for the nine months ended September 30, 2025, Adjusted EBITDA was $3.7M, down from $6.5M in the prior year period.
Cash and cash equivalents as of September 30, 2025 were $1.4M; as of November 7, 2025, cash was approximately $2.1M.
Q3 cash collections totaled $10.0M, compared to $11.2M in Q3 2024 and $7.5M pro forma.
Outlook and guidance
Management anticipates that current cash and forecasted receipts will be sufficient to meet anticipated cash requirements for the next twelve months.
The company continues to explore strategic alternatives and funding options due to capital market constraints following delisting from Nasdaq.
Management expressed confidence in continued growth in revenue, profitability, and cash flow as a thyroid-only diagnostics business.
Ongoing focus on reimbursement improvements and operational efficiency expected to support future performance.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Interpace Biosciences earnings date
Q4 202531 Mar, 2026
Next Interpace Biosciences earnings date
Q4 202531 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Interpace Biosciences, Inc. is a U.S.-based company specializing in molecular diagnostic tests and pathology services. The company provides diagnostic solutions for detecting, monitoring, and managing risks related to cancer, particularly in areas such as thyroid, gastrointestinal, and lung cancers. Interpace Biosciences serves healthcare providers, patients, and pharmaceutical companies by offering personalized diagnostic information to guide clinical decision-making. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the OTCQB.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage